Expression of Cardiac Specific Cell Marker in Ex Vivo Differentiated Canine iPSC

Induced Pluripotent stem cells (iPSC) have a high ability to renew and differentiate themselves into various lineages and as vehicles of cell based therapy. Stem cell can differentiate under appropriate in vitro and in vivo conditions into different cell types. This study described the establishment of condition for in vitro expression of alpha MHC gene in cardiac differentiated canine iPSC (ciPSC). In vitro differentiation of canine iPSC5 via embryoid bodies (EBs) were produced by 'Hanging Drop' method. EB's were differentiated by using IMDM differentiation media: FBS - 10%, NEAA (100X) - 0.5%, B-Mercaptoethanol- 100mM, Gentamycin- 5pg/ml supplemented with Azacytidine- 0.5 mu M. During differentiation, EBs were collected on day 4, 6, 8, 12, 16, 20 and 24 for characterization of cardiomyocytes specific marker expression. Total RNA from EBs were extracted by using Trizol method and subsequently cDNA were synthesized. The differentiated cells expressed cardiac specific gene (Alpha MHC) which started from day 6 of differentiation upto day 24 Immunocytochemistry and relative expression of cardiac specific genes revealed that ciPSC have the potential to differentiate into cardiomyocytes which can be used for cardiac tissue regeneration and as disease models for pharmaceutical testing.